HK1016177A1 - New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency - Google Patents

New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency

Info

Publication number
HK1016177A1
HK1016177A1 HK99101299A HK99101299A HK1016177A1 HK 1016177 A1 HK1016177 A1 HK 1016177A1 HK 99101299 A HK99101299 A HK 99101299A HK 99101299 A HK99101299 A HK 99101299A HK 1016177 A1 HK1016177 A1 HK 1016177A1
Authority
HK
Hong Kong
Prior art keywords
oxyalkoxyphenyl
piperidines
oxy
new
treating heart
Prior art date
Application number
HK99101299A
Other languages
English (en)
Inventor
Alfred Binggeli
Volker Breu
Daniel Bur
Walter Fischli
Rolf Gueller
Georges Hirth
Hans-Peter Maerki
Marcel Mueller
Christian Oefner
Heinz Stadler
Eric Viera
Marice Wilhelm
Wolfgang Wost
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1016177A1 publication Critical patent/HK1016177A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
HK99101299A 1995-09-07 1999-03-30 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency HK1016177A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH254895 1995-09-07
CH187696 1996-07-26
PCT/EP1996/003803 WO1997009311A1 (fr) 1995-09-07 1996-08-29 Nouvelles 4-(oxyalcoxyphenyl)-3-oxy-piperidines utiles pour traiter l'insuffisance cardiaque et renale

Publications (1)

Publication Number Publication Date
HK1016177A1 true HK1016177A1 (en) 1999-10-29

Family

ID=25688898

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99101299A HK1016177A1 (en) 1995-09-07 1999-03-30 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency

Country Status (27)

Country Link
US (2) US6051712A (fr)
EP (1) EP0863875B1 (fr)
JP (1) JP3648251B2 (fr)
KR (1) KR100384979B1 (fr)
CN (1) CN1256326C (fr)
AT (1) ATE242213T1 (fr)
BR (1) BR9610385A (fr)
CA (1) CA2230931C (fr)
CY (1) CY2488B1 (fr)
CZ (1) CZ292327B6 (fr)
DE (1) DE59610509D1 (fr)
DK (1) DK0863875T3 (fr)
ES (1) ES2201192T3 (fr)
HK (1) HK1016177A1 (fr)
HU (1) HUP9900926A3 (fr)
IL (1) IL123293A (fr)
MA (1) MA23967A1 (fr)
MY (1) MY121967A (fr)
NO (1) NO310069B1 (fr)
NZ (1) NZ315677A (fr)
PL (1) PL193686B1 (fr)
PT (1) PT863875E (fr)
RU (1) RU2167865C2 (fr)
SA (1) SA96170317B1 (fr)
TR (1) TR199800409T1 (fr)
TW (1) TW474932B (fr)
WO (1) WO1997009311A1 (fr)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
JP2001525812A (ja) 1997-05-14 2001-12-11 ニューロサーアチ・アクティーゼルスカブ 神経伝達物質再吸収阻害剤としてのピペリジン誘導体
HUP0003958A3 (en) 1997-05-29 2001-06-28 Smithkline Beecham Plc Process for preparation of 4-aryl-piperidines and intermediates
WO1999012532A2 (fr) * 1997-09-08 1999-03-18 F.Hoffmann-La Roche Ag Derives de piperidine contre la malaria
TR200002904T2 (tr) 1998-04-10 2001-02-21 Japan Tobacco Inc. Amidin bileşikleri
US6268499B1 (en) * 1998-08-10 2001-07-31 Hoffman-La Roche Inc. Process and intermediates for preparation of substituted piperidine-epoxides
US6274735B1 (en) 1998-08-10 2001-08-14 Hoffmann-La Roche Inc. Process and intermediates for preparation of substituted piperidines
WO2000063173A1 (fr) * 1999-04-14 2000-10-26 F. Hoffmann-La Roche Ag Procede de preparation de piperidines substituees
US6197959B1 (en) * 1999-04-27 2001-03-06 Hoffmann-La Roche Inc. Piperidine derivatives
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
IT1313702B1 (it) * 1999-08-02 2002-09-09 Chemi Spa Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
CA2383524C (fr) * 1999-08-31 2010-09-28 Merck & Co., Inc. Composes heterocycliques et procedes d'utilisation de ceux-ci
RU2257382C2 (ru) * 1999-10-15 2005-07-27 Ф.Хоффманн-Ля Рош Аг Производные бензодиазепина, лекарственное средство, содержащее их, и способ их получения
DE60113104D1 (de) * 2000-06-13 2005-10-06 Basf Ag 5 phenyl substituierte 2-(cyanoamino)-pyrimidine als fungizide
US20060079533A1 (en) * 2001-03-23 2006-04-13 Nieman James A Methods of treating alzheimer's disease
OA12812A (en) * 2001-11-19 2006-07-10 Elan Pharm Inc (4-phenyl) Piperidin-3-yl-phenylcarboxylate derovatoves and related compounds as beta-secretase inhibitors for the treatment of Alzheimer's Disease.
BR0309498A (pt) * 2002-04-29 2005-02-15 Actelion Pharmaceuticals Ltd Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças que são relacionadas com o ras, e, uso de compostos
AU2003229746A1 (en) * 2002-06-27 2004-01-19 Actelion Pharmaceuticals Ltd Novel tetrahydropyridine derivatives as renin inhibitors
JP2006519229A (ja) 2003-02-13 2006-08-24 アルバート・アインシュタイン・カレッジ・オヴ・メディシン・オヴ・イェシヴァ・ユニヴァーシティ 視床下部内の長鎖脂肪アシルＣｏＡレベルの変調による摂食量およびグルコース産生量の調節
US20040204455A1 (en) * 2003-04-10 2004-10-14 Cody Wayne Livingston Piperidine derivative rennin inhibitors
US20040214832A1 (en) * 2003-04-10 2004-10-28 Cuiman Cai Piperazine derivative renin inhibitors
CN1780836A (zh) * 2003-04-28 2006-05-31 埃科特莱茵药品有限公司 作为血管紧张肽原酶抑制剂的新型二氮杂双环壬烯和四氢吡啶衍生物
BRPI0409881A (pt) * 2003-04-29 2006-05-23 Actelion Pharmaceuticals Ltd compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
MXPA05011496A (es) * 2003-04-30 2005-12-15 Actelion Pharmaceuticals Ltd Derivados de azabiciclononeno.
AU2004234042A1 (en) * 2003-04-30 2004-11-11 Actelion Pharmaceuticals Ltd Tropane derivatives and their use as ACE inhibitors
WO2004096366A1 (fr) * 2003-04-30 2004-11-11 Actelion Pharmaceuticals Ltd Derives de 9-azabicyclo'3.3.1!non-6-ee a heteroatome en position 3 servant d'inhibiteurs de la renine
BRPI0409882A (pt) * 2003-05-02 2006-05-23 Actelion Pharmaceuticals Ltd compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
CN1856484B (zh) 2003-07-24 2010-09-22 欧洲凯尔蒂克公司 用于治疗或预防疼痛的杂芳基-四氢吡啶基化合物
TW200900399A (en) 2003-10-01 2009-01-01 Speedel Experimenta Ag Organic compounds
AR045950A1 (es) * 2003-10-09 2005-11-16 Speedel Experimenta Ag Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.
CA2540817A1 (fr) * 2003-10-23 2005-05-06 Olivier Bezencon Derives de diazabicyclononene et de tetrahydropyridine utilises comme inhibiteurs de la renine
JP4750712B2 (ja) * 2003-11-26 2011-08-17 ノバルティス アーゲー レニン阻害剤としての４−フェニルピペリジン誘導体
JP2007529459A (ja) 2004-03-17 2007-10-25 ノバルティス アクチエンゲゼルシャフト 治療に置けるレニン阻害剤の使用
JP2007223901A (ja) * 2004-03-24 2007-09-06 Takeda Chem Ind Ltd 複素環化合物およびその用途
TW200613274A (en) * 2004-07-09 2006-05-01 Speedel Experimenta Ag Organic compounds
JP2008510755A (ja) 2004-08-25 2008-04-10 アクテリオン ファーマシューティカルズ リミテッド ビシクロノネン誘導体
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0500784D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
WO2006079988A1 (fr) * 2005-01-28 2006-08-03 Actelion Pharmaceuticals Ltd Acide 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-6-carboxylique cyclopropyl-(2,3-dimethylbenzyl)amide utilises comme inhibiteurs de la renine pour le traitement de l'hypertension
TW200722424A (en) 2005-03-31 2007-06-16 Speedel Experimenta Ag Substituted piperidines
CN101151262B (zh) * 2005-03-31 2011-07-06 斯皮德尔实验股份公司 取代的哌啶
EP1863763A1 (fr) * 2005-03-31 2007-12-12 Speedel Experimenta AG Piperidine a substitution 3,4,5 utiles en tant qu'inhibiteurs de la renine
EP1897879A3 (fr) 2005-03-31 2008-06-11 Speedel Experimenta AG Pipéridines 2,4,5-substituées comme inhibiteurs de la rénine
EP1707202A1 (fr) * 2005-03-31 2006-10-04 Speedel Experimenta AG Composes organiques
AR055756A1 (es) 2005-03-31 2007-09-05 Speedel Experimenta Ag Piperidinas sustituidas; procesos de preparacion y su uso como medicamentos
GB0508992D0 (en) * 2005-05-03 2005-06-08 Novartis Ag Organic compounds
GB0510810D0 (en) * 2005-05-26 2005-06-29 Novartis Ag Organic compounds
RU2410374C2 (ru) 2005-05-27 2011-01-27 Актелион Фармасьютикалз Лтд Новые амидные производные пиперидинкарбоновой кислоты
WO2006131884A2 (fr) * 2005-06-07 2006-12-14 Actelion Pharmaceuticals Ltd Nouveaux derives de thiazole
GB0514203D0 (en) 2005-07-11 2005-08-17 Novartis Ag Organic compounds
CA2616937A1 (fr) 2005-07-29 2007-02-08 F. Hoffman-La Roche Ag Derives de indol-3-yl-carbonyl-piperidine et piperazine
US20070142389A1 (en) * 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives
AU2006332124B2 (en) 2005-12-30 2011-03-03 Novartis Ag 3 , 5-substitgammaued piperidine compounds as renin inhibitors
EP1816122A3 (fr) * 2006-01-19 2007-09-19 Speedel Experimenta AG Pipéridines substituées 3,4,5 en tant que composants thérapeutiques
TW200804359A (en) * 2006-01-19 2008-01-16 Speedel Experimenta Ag Substituted 4-phenylpiperidines
EP1981847A1 (fr) 2006-02-02 2008-10-22 Actelion Pharmaceuticals Ltd. Amines secondaires en tant qu'inhibiteurs de la rénine
WO2007120523A2 (fr) * 2006-03-31 2007-10-25 Vitae Pharmaceuticals, Inc. 6-(aminoalkyl)indazoles
ES2373792T3 (es) 2006-05-19 2012-02-08 Abbott Laboratories Derivados de alcanos azabicíclicos sustituidos con bicicloheterociclo condensado activos en el snc.
JP2009539806A (ja) * 2006-06-08 2009-11-19 シュペーデル・エクスペリメンタ・アーゲー ２，５−二置換ピペリジン
CL2007002689A1 (es) 2006-09-18 2008-04-18 Vitae Pharmaceuticals Inc Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
CA2668742A1 (fr) * 2006-11-17 2008-05-22 Merck Frosst Canada Ltd. Inhibiteurs de la renine
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
EP1987834A3 (fr) 2007-02-13 2008-11-19 Speedel Experimenta AG Pipéridines substituées en tant que composants thérapeutiques
JP2010524879A (ja) * 2007-04-19 2010-07-22 エフ．ホフマン−ラ ロシュ アーゲー ジヒドロ−ベンゾ［ｂ］［１，４］ジアゼピン−２−オンスルホンアミド誘導体
CA2833209C (fr) * 2007-04-27 2016-06-28 Purdue Pharma L.P. Composes de piperidine et piperazine en tant qu'antagonistes de trpv1
WO2009000811A1 (fr) 2007-06-25 2008-12-31 Novartis Ag Composés organiques
AU2008279447A1 (en) 2007-07-19 2009-01-29 Metabolex, Inc. N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
EP2018862A1 (fr) 2007-07-25 2009-01-28 Speedel Experimenta AG Pipéridines substituées en tant que composants thérapeutiques
AR068887A1 (es) 2007-10-18 2009-12-16 Speedel Experimenta Ag Piperidinas trisustituidas
AR069005A1 (es) * 2007-10-25 2009-12-23 Speedel Experimenta Ag Piperidinas 4,4-disustituidas
AR069145A1 (es) * 2007-11-02 2009-12-30 Speedel Experimenta Ag Piperidinas 4,4- disusutituidas, uso del compuesto en la produccion de un medicamento, un producto farmaceutico en base al compuesto y un metodo de prevencion de enfermedades
TW200932241A (en) 2007-12-05 2009-08-01 Speedel Experimenta Ag Organic compounds
WO2009106599A2 (fr) * 2008-02-29 2009-09-03 Novartis Ag Pipéridines substituées en tant que composés thérapeutiques
BRPI0909469A2 (pt) * 2008-03-31 2015-12-29 Metabolex Inc compostos de oximetileno de arila e usos dos mesmos
MY152042A (en) 2008-05-05 2014-08-15 Actelion Pharmaceuticals Ltd 3,4- substituted piperidine derivatives as renin inhibitors
AU2009271414A1 (en) * 2008-06-20 2010-01-21 Metabolex, Inc. Aryl GPR119 agonists and uses thereof
WO2010013849A1 (fr) * 2008-08-01 2010-02-04 日本ケミファ株式会社 Agoniste de gpr119
EP2163245A1 (fr) 2008-09-10 2010-03-17 Novartis Ag Inhibiteurs de la rénine pour le traitement du psoriasis
JP2010090110A (ja) * 2008-09-12 2010-04-22 Sumitomo Chemical Co Ltd Ｎ−置換−トランス−４−アジドピペリジン−３−オールの製造方法
AU2009326797B2 (en) * 2008-12-10 2012-12-13 Merck Canada Inc. 3,4 - substituted piperidine derivatives as renin inhibitors
WO2010122580A2 (fr) 2009-04-24 2010-10-28 Cadila Healthcare Limited Nouveaux composés inhibiteurs de rénine
WO2011030139A1 (fr) 2009-09-11 2011-03-17 Astrazeneca Ab Derives de 4-(pyrimidin-2-yl)-piperazine et de 4-(pyrimidin-2-yl)-piperidine utilises en tant que modulateurs du gpr119
ES2497566T3 (es) 2009-10-01 2014-09-23 Cymabay Therapeutics, Inc. Sales de tetrazol-1-il-fenoximetil-tiazol-2-il-piperidinil-pirimidina sustituida
BR112012032248A2 (pt) 2010-06-23 2016-09-13 Metabolex Inc composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
US20120184572A1 (en) * 2011-01-13 2012-07-19 Metabolex, Inc. Aryl gpr119 agonists and uses thereof
EP2723732B1 (fr) 2011-06-22 2017-01-18 Purdue Pharma LP Antagonistes de trpv1 comprenant un substituant dihydroxy et leurs utilisations
WO2013088452A2 (fr) 2011-11-11 2013-06-20 Sun Pharma Advanced Research Company Ltd. Dérivés de quinoléine utilisés en tant qu'inhibiteurs de la rénine
WO2013084241A1 (fr) 2011-12-09 2013-06-13 Cadila Healthcare Limited Composés inhibiteurs de rénine
CN104370813A (zh) * 2014-10-22 2015-02-25 上海大学 异喹啉-6-甲醛的制备方法
WO2018026890A1 (fr) 2016-08-03 2018-02-08 Cymabay Therapeutics Composés d'aryle d'oxyméthylène pour le traitement de maladies gastro-intestinales inflammatoires ou de troubles gastro-intestinaux
CN110041212B (zh) * 2019-05-21 2020-10-02 吉林大学 一种含氟多胺单体及其制备方法、一种聚酰亚胺及其制备方法和一种聚酰亚胺膜

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545792B2 (de) * 1965-02-27 1975-08-07 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von 4-Hydroxyplperidinen
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
IE45511B1 (en) * 1976-09-01 1982-09-08 Ciba Geigy Ag New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
US5272156A (en) * 1989-09-19 1993-12-21 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5545658A (en) * 1991-03-26 1996-08-13 Hoffman-La Roche Inc. Amino acid derivatives
RU2097378C1 (ru) * 1991-03-26 1997-11-27 Ф.Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ N-АЦИЛ- α -АМИНОКИСЛОТЫ ИЛИ ИХ ФИЗИОЛОГИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, ПРОСТЫЕ ИЛИ СЛОЖНЫЕ ЭФИРЫ, АМИДЫ ИЛИ ГИДРАТЫ И КОМПОЗИЦИЯ ИНГИБИРУЮЩАЯ СВЯЗЫВАНИЕ АДГЕЗИВНЫХ ПРОТЕИНОВ С ТРОМБОЦИТАМИ И АГРЕГАЦИЮ ТРОМБОЦИТОВ

Also Published As

Publication number Publication date
CA2230931A1 (fr) 1997-03-13
KR100384979B1 (ko) 2003-10-17
TR199800409T1 (xx) 1998-05-21
MA23967A1 (fr) 1997-04-01
EP0863875A1 (fr) 1998-09-16
KR19990044459A (ko) 1999-06-25
AU708616B2 (en) 1999-08-05
CZ292327B6 (cs) 2003-09-17
HUP9900926A2 (hu) 1999-09-28
ES2201192T3 (es) 2004-03-16
WO1997009311A1 (fr) 1997-03-13
DE59610509D1 (de) 2003-07-10
EP0863875B1 (fr) 2003-06-04
CN1256326C (zh) 2006-05-17
US6051712A (en) 2000-04-18
JP3648251B2 (ja) 2005-05-18
BR9610385A (pt) 1999-07-06
CY2488B1 (en) 2005-06-03
PL193686B1 (pl) 2007-03-30
CA2230931C (fr) 2009-05-19
NZ315677A (en) 2000-02-28
US6150526A (en) 2000-11-21
PL325425A1 (en) 1998-07-20
CZ68498A3 (cs) 1998-10-14
TW474932B (en) 2002-02-01
DK0863875T3 (da) 2003-12-01
MY121967A (en) 2006-03-31
MX9801814A (es) 1998-08-30
NO980954D0 (no) 1998-03-05
RU2167865C2 (ru) 2001-05-27
IL123293A0 (en) 1998-09-24
NO310069B1 (no) 2001-05-14
IL123293A (en) 2003-06-24
SA96170317B1 (ar) 2006-05-13
JPH11500447A (ja) 1999-01-12
NO980954L (no) 1998-04-28
ATE242213T1 (de) 2003-06-15
AU6743296A (en) 1997-03-27
PT863875E (pt) 2003-10-31
HUP9900926A3 (en) 2002-12-28
CN1202152A (zh) 1998-12-16

Similar Documents

Publication Publication Date Title
HK1016177A1 (en) New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
NZ325449A (en) Naphthyl-substituted benzimidazole derivatives as anticoagulants
HK1026691A1 (en) Substituted benzimidazoles and their use for treating retroviral infection
KR900700486A (ko) 신규한 벤조피리도 피페리딘, 피페리딜리덴 및 피페라진 화합물, 조성물, 제조방법 및 이용방법
MX9707453A (es) Derivados de quinazolina.
TR200100238T2 (tr) Yeni sübstitüe edilmiş pirazol türevleri
DE69817802D1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
ZA9710796B (en) Oxyiminopregnanecarbolactones.
ATE211732T1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
ATE218329T1 (de) Anthracyclinon-derivate und ihre verwendung in amyloidose
AU6822798A (en) Cycloalkylalkanecarboxamides and the production and use thereof
NO981393L (no) Guanidinoproteasehemmere
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
MX9601635A (es) Derivados de antraciclina.
DK0720617T3 (da) Hidtil ukendte urethanholdige aminosteroidforbindelser
DE59901563D1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
ATE183502T1 (de) Octahydro-2-naphthalincarbonsäure-derivate, ihre herstellung und verwendung
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
SE9603284D0 (sv) New compounds
YU37902A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3- benzazocini i njihova primena kao lekova
EP0367671A3 (fr) Bêta-D-phénylthioxylosides, procédé pour leur préparation et leur utilisation comme médicaments

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130829